Sale of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities as set forth in Section 2(e) above is predicated upon the Company’s reliance that the Holder will sell this Warrant or any Exercise Shares and/or any Failure Payment Shares, as applicable, pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 13 contracts
Samples: Warrant Agreement (Infinity Pharmaceuticals, Inc.), Warrant Agreement (Alphatec Holdings, Inc.), Warrant Agreement (Infinity Pharmaceuticals, Inc.)
Sale of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities Securities as set forth in this Section 2(e2(e)(i) above is predicated upon the Company’s reliance that the Holder will sell this Warrant or any Exercise Shares and/or any Failure Payment Shares, as applicable, pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities Securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 10 contracts
Samples: Series C Preferred Stock and Warrant Purchase Agreement (VirtualScopics, Inc.), Warrant Agreement (VirtualScopics, Inc.), Warrant Agreement (QPC Lasers)
Sale of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities Securities as set forth in this Section 2(e2(g)(i) above is predicated upon the Company’s reliance that the Holder will sell this Warrant or any Exercise Shares and/or any Failure Payment Shares, as applicable, pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities Securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 9 contracts
Samples: Series C Preferred Stock and Warrant Purchase Agreement (VirtualScopics, Inc.), Warrant Agreement (VirtualScopics, Inc.), Warrant Agreement (ICP Solar Technologies Inc.)
Sale of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities as set forth in Section 2(e) above is predicated upon the Company’s reliance that the Holder will sell sell, transfer, assign, pledge, hypothecate or otherwise dispose of this Warrant or any Exercise Shares and/or any Failure Payment Shares, as applicable, pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 9 contracts
Samples: Warrant Agreement (Power Solutions International, Inc.), Warrant Agreement (Weichai America Corp.), Warrant Agreement (Weichai America Corp.)
Sale of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities Securities as set forth in this Section 2(e2(e)(i) above is predicated upon the Company’s 's reliance that the Holder will sell this Warrant or any Exercise Shares and/or any Failure Payment Shares, as applicable, pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities Securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 7 contracts
Samples: Warrant Agreement (Universal Energy Corp.), Warrant Agreement (Universal Energy Corp.), Warrant Agreement (Universal Energy Corp.)
Sale of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities Securities as set forth in Section 2(e2(d)(i) above is predicated upon the Company’s reliance that the Holder will sell this Warrant or any Exercise Shares and/or any Failure Payment Shares, as applicable, pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities Securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 5 contracts
Samples: Warrant Agreement (Jammin Java Corp.), Warrant Agreement (Jammin Java Corp.), Warrant Agreement (Jammin Java Corp.)
Sale of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities as set forth in Section 2(e) above is predicated upon the Company’s reliance that the Holder will sell this Warrant or any Exercise Shares and/or any Failure Payment Shares, as applicable, pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 5 contracts
Samples: Warrant Agreement (Nuo Therapeutics, Inc.), Warrant Agreement (Cytomedix Inc), Warrant Agreement (Tengion Inc)
Sale of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities as set forth in Section 2(e3(e)(i) above is predicated upon the Company’s reliance that the Holder will sell this Warrant or any Exercise Conversion Shares and/or any Failure Payment Shares, as applicable, pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 4 contracts
Samples: Merger Agreement (Aytu Bioscience, Inc), Subordination Agreement (Neos Therapeutics, Inc.), Subordination Agreement (Neos Therapeutics, Inc.)
Sale of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities shares of Common Stock issuable upon Exercise of this Warrant as set forth in Section 2(e) above is predicated upon the Company’s reliance that the Holder will sell this Warrant or any Exercise Shares and/or any Failure Payment Shares, as applicable, pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 4 contracts
Samples: Second Lien Credit and Guaranty Agreement (Lannett Co Inc), Exchange Agreement (Lannett Co Inc), Exchange Agreement (Lannett Co Inc)
Sale of Unlegended Shares. The Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities shares of Common Stock issuable upon Exercise of this Warrant as set forth in this Section 2(e) above is predicated upon the Company’s reliance that the Holder will sell this Warrant or any Exercise Shares and/or any Failure Payment Shares, as applicable, pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration StatementStatement and applicable state securities laws, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 4 contracts
Samples: Warrant Agreement (Sunpower Corp), Warrant Agreement (TotalEnergies SE), Warrant Agreement (Global Infrastructure Investors III, LLC)
Sale of Unlegended Shares. The Holder agrees that the removal of the restrictive legend from this Warrant Certificate and any certificates representing securities as set forth in Section 2(e11(a)(ii) above is predicated upon the Company’s reliance that the Holder will sell this Warrant Certificate or any Exercise Shares and/or any Failure Payment Shares, as applicable, such securities pursuant to either an effective Registration Statement or otherwise pursuant to the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 3 contracts
Samples: Credit Agreement and Guaranty (Pear Therapeutics, Inc.), Credit Agreement and Guaranty (Pear Therapeutics, Inc.), Credit Agreement (Thimble Point Acquisition Corp.)
Sale of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities as set forth in Section 2(e) above is predicated upon the Company’s reliance that the Holder will sell this Warrant or any Exercise Shares and/or any Failure Payment Shares, as applicable, pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 3 contracts
Samples: Facility Agreement (Endologix Inc /De/), Facility Agreement (Endologix Inc /De/), Warrant Agreement (Endologix Inc /De/)
Sale of Unlegended Shares. The Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities as set forth in Section 2(e5(c) above is predicated upon the Company’s reliance that the Holder will sell this Warrant or any Exercise Shares and/or any Failure Payment Shares, as applicable, such securities pursuant to either an effective Registration Statement or otherwise pursuant to the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 3 contracts
Samples: Security Agreement, Security Agreement (CareDx, Inc.), Security Agreement (NXT-Id, Inc.)
Sale of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities as set forth in Section 2(e2(e)(i) above is predicated upon the Company’s reliance that the Holder will sell this Warrant or any Exercise Conversion Shares and/or any Failure Payment Shares, as applicable, pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 3 contracts
Samples: Senior Secured Convertible Note (Neos Therapeutics, Inc.), Facility Agreement, Facility Agreement (Neos Therapeutics, Inc.)
Sale of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities as set forth in Section 2(e2(e)(ii) above is predicated upon the Company’s reliance that the Holder will sell this Warrant or any Exercise Shares and/or any Failure Payment Shares, as applicable, pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 3 contracts
Samples: Warrant Agreement (Melinta Therapeutics, Inc. /New/), Warrant Agreement (Melinta Therapeutics, Inc. /New/), Warrant Agreement (Melinta Therapeutics, Inc. /New/)
Sale of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities as set forth in this Section 2(e2(e)(ii) above is predicated upon the Company’s reliance that the Holder will sell this Warrant or any Warrant, Exercise Shares and/or any Failure Payment Shares, as applicable, Redemption Shares pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 3 contracts
Samples: Warrant Agreement (Array Biopharma Inc), Warrant Agreement (Array Biopharma Inc), Warrant Agreement (Array Biopharma Inc)
Sale of Unlegended Shares. Holder agrees that the removal of the restrictive United States legend from this Warrant Note and any certificates representing securities as set forth in Section 2(e2(e)(i) above is predicated upon the Company’s reliance that the Holder will sell this Warrant Note or any Exercise Shares and/or any Failure Payment Conversion Shares, as applicable, pursuant to either the registration requirements of the Securities ActAct and applicable state securities laws, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 2 contracts
Samples: Facility Agreement (Tribute Pharmaceuticals Canada Inc.), Facility Agreement (Pozen Inc /Nc)
Sale of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities as set forth in Section 2(e) above is predicated upon the Company’s reliance that the Holder will sell this Warrant sell, transfer, assign, pledge, hypothecate or any otherwise dispose of the Exercise Shares and/or any Failure Payment Shares, as applicable, pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 2 contracts
Samples: Warrant Agreement (Avadel Pharmaceuticals PLC), Warrant Agreement (Avadel Pharmaceuticals PLC)
Sale of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities as set forth in Section 2(e2(e)(i) above is predicated upon the Company’s reliance that the Holder will sell this Warrant or and/or any Exercise Shares and/or any Failure Payment Shares, as applicable, pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 2 contracts
Samples: Warrant Agreement (Hana Biosciences Inc), Warrant Agreement (Hana Biosciences Inc)
Sale of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities as set forth in Section 2(e) above is predicated upon the Company’s reliance that the Holder will sell this Warrant or any such Exercise Shares and/or any Failure Payment Shares, as applicable, pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an a valid exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 2 contracts
Samples: Facility Agreement (Kempharm, Inc), Warrant Agreement (Kempharm, Inc)
Sale of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities Exercise Shares as set forth in Section 2(e2(e)(i) above is predicated upon the Company’s reliance that the Holder will sell this Warrant or and/or any Exercise Shares and/or any Failure Payment Shares, as applicable, pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 2 contracts
Samples: Warrant Agreement (Third Wave Technologies Inc /Wi), Warrant Agreement (Third Wave Technologies Inc /Wi)
Sale of Unlegended Shares. The Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities as set forth in Section 2(e11(a)(ii) above is predicated upon the Company’s reliance that the Holder will sell this Warrant or any Exercise Shares and/or any Failure Payment Shares, as applicable, such securities pursuant to either an effective Registration Statement or otherwise pursuant to the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 1 contract
Samples: Warrant Agreement (Icagen, Inc.)
Sale of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities as set forth in this Section 2(e2(e)(i) above is predicated upon the Company’s reliance that the Holder will sell this Warrant or and/or any Exercise Shares and/or any Failure Payment Shares, as applicable, pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 1 contract
Samples: Warrant Agreement (MiddleBrook Pharmaceuticals, Inc.)
Sale of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Warrant Note and any certificates representing securities as set forth in Section 2(e) above is predicated upon the Company’s reliance that the Holder will sell this Warrant Note or any Exercise Shares and/or any Failure Payment Conversion Shares, as applicable, pursuant to either the registration requirements of the Securities ActAct and applicable state securities laws, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 1 contract
Samples: Facility Agreement (Pozen Inc /Nc)
Sale of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities Exercise Shares and/or Additional Shares as set forth in Section 2(e2(e)(i) above is predicated upon the Company’s reliance that the Holder will sell this Warrant or any Warrant, Exercise Shares and/or any Failure Payment Shares, as applicable, or Additional Shares pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 1 contract
Sale of Unlegended Shares. The Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities as set forth in Section 2(e10(a)(ii) above is predicated upon the Company’s reliance upon the Holder’s agreement that the Holder it will sell this Warrant or any Exercise Shares and/or any Failure Payment Shares, as applicable, such securities pursuant to either an effective Registration Statement or otherwise pursuant to the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 1 contract
Samples: Credit Agreement (Invitae Corp)
Sale of Unlegended Shares. Holder agrees that the removal of the any restrictive legend legends from this Warrant and any certificates representing securities as set forth in this Section 2(e) above is predicated upon the Company’s reliance that the Holder will sell this Warrant or any Exercise such Conversion Shares and/or any Failure Payment Shares, as applicable, pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statementregistration statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 1 contract
Samples: Facility Agreement (Kempharm, Inc)
Sale of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities as set forth in Section 2(e2(e)(ii) above is predicated upon the Company’s reliance that the Holder will sell this Warrant or any Exercise Shares and/or any Failure Payment Shares, as applicable, pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 1 contract
Samples: Warrant Agreement (Nevro Corp)
Sale of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities the Exercise Shares or the Failure Payment Shares as set forth in Section 2(e) above is predicated upon the Company’s reliance that the Holder will sell this Warrant or any Exercise Shares and/or any Failure Payment Shares, as applicable, pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 1 contract
Samples: Facility Agreement (IMRIS Inc.)
Sale of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Warrant Note and any certificates representing securities as set forth in Section 2(e) above is predicated upon the Company’s reliance that the Holder will sell this Warrant Note or any Exercise Shares and/or any Failure Payment Exchange Shares, as applicable, pursuant to either the registration requirements of the Securities ActAct and applicable state securities laws, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 1 contract
Samples: Facility Agreement (Pozen Inc /Nc)
Sale of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Warrant and any certificates representing securities as set forth in Section 2(e) above is predicated upon the Company’s reliance that the Holder will sell this Warrant or any Exercise Conversion Shares and/or any Failure Payment Shares, as applicable, pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 1 contract
Samples: Facility Agreement and Registration Rights Agreement (Mannkind Corp)
Sale of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Warrant and any certificates (or from Conversion Shares in a Holder’s or its designee’s balance account with DTC) representing securities as set forth in Section 2(e) above is predicated upon the Company’s reliance that the Holder will sell this Warrant or any Exercise Conversion Shares and/or any Failure Payment Shares, as applicable, pursuant to either the registration requirements of the Securities ActAct and applicable state securities laws, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 1 contract
Sale of Unlegended Shares. The Holder agrees that the removal of the any restrictive legend legends from this Warrant and any certificates representing securities as set forth in this Section 2(e2(d) above is predicated upon the Company’s reliance that the Holder will sell this Warrant or any Exercise Shares and/or any Failure Payment Shares, as applicable, such securities pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, Act or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statementregistration statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 1 contract
Sale of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Warrant Note and any certificates representing securities as set forth in Section 2(e) above is predicated upon the Company’s reliance that the Holder will sell this Warrant Note or any Exercise Shares and/or any Failure Payment Conversion Shares, as applicable, pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.
Appears in 1 contract
Samples: Note Purchase Agreement (Aerie Pharmaceuticals Inc)